Evidence map›Paper›PMID 23643539›Full record

ArticleCell reports2013

A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.

Julie Adam, Ming Yang, Christina Bauerschmidt, Mitsuhiro Kitagawa, Linda O'Flaherty, Pratheesh Maheswaran, Gizem Özkan, Natasha Sahgal, Dilair Baban, Keiko Kato and 13 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Subcellular localization as a driver of protein function.Nature reviews. Molecular cell biology · 2026
    Review
  3. Article
  4. Article
  5. Nitrogen Isotope Effects in Urea Metabolism: From Biochemistry toInternational journal of molecular sciences · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Targeted Integration of Transgenes at the Mouse Gt(ROSA)26Sor Locus.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 3 countries.

Julie AdamCancer Biology and Metabolism Group, Nuffield Department of Medicine, Henry Wellcome Building for Molecular Physiology, University of Oxford, Oxford OX3 7BN, UK.
Ming Yang
Christina Bauerschmidt
Mitsuhiro Kitagawa
Linda O'Flaherty
Pratheesh Maheswaran
Gizem Özkan
Natasha Sahgal
Dilair Baban
Keiko Kato
Kaori Saito
Keiko Iino
Kaori Igarashi
Michael Stratford
Christopher Pugh
Daniel A Tennant
Christian Ludwig
Benjamin Davies
Peter J Ratcliffe
Mona El-Bahrawy
Houman Ashrafian
Tomoyoshi Soga
Patrick J Pollard
University of Oxford · GBKeio University · JPUniversity of Birmingham · GBAlexandria University · EGCRUK/MRC Oxford Institute for Radiation Oncology · GB

Funding

Cancer Research UK 13349Cancer Research UK A12027Cancer Research UK A13349Cancer Research UK A14607European Research Council 310837Wellcome Trust 090532Wellcome Trust 090532/Z/09/ZWellcome Trust WT091112MA
6 · The paper itself

Abstract

The identification of mutated metabolic enzymes in hereditary cancer syndromes has established a direct link between metabolic dysregulation and cancer. Mutations in the Krebs cycle enzyme, fumarate hydratase (FH), predispose affected individuals to leiomyomas, renal cysts, and cancers, though the respective pathogenic roles of mitochondrial and cytosolic FH isoforms remain undefined. On the basis of comprehensive metabolomic analyses, we demonstrate that FH1-deficient cells and tissues exhibit defects in the urea cycle/arginine metabolism. Remarkably, transgenic re-expression of cytosolic FH ameliorated both renal cyst development and urea cycle defects associated with renal-specific FH1 deletion in mice. Furthermore, acute arginine depletion significantly reduced the viability of FH1-deficient cells in comparison to controls. Our findings highlight the importance of extramitochondrial metabolic pathways in FH-associated oncogenesis and the urea cycle/arginine metabolism as a potential therapeutic target.

Indexed as

AnimalsArginineArgininosuccinic AcidCell LineCitric Acid CycleFumarate HydrataseFumaratesKidneyKidney NeoplasmsMetabolomeMiceMice, KnockoutMice, TransgenicMitochondriaMutationProtein IsoformsArginineArgininosuccinic AcidFumarate HydrataseFumaratesProtein IsoformsUrea

Identifiers

PMID23643539
PMCPMC3675675
OpenAlexW2051992679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.